Whitehawk Therapeutics, Inc. Common Stock WHWK Cash Flow Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| -$20.6M+67.7% | -$63.69M+3.2% | -$65.77M— | ||
| $78.9K-59.2% | $193.3K+14.4% | $169K— | ||
| $9.87M-8.9% | $10.84M-9.3% | $11.95M— | ||
| -$97.43M-63.6% | -$59.55M+0.2% | -$59.66M— | ||
| —— | $1.65M-58.4% | $3.97M— | ||
| —— | —— | $83.21M— | ||
| —— | $130K— | —— | ||
| —— | -$34.22M— | —— | ||
| -$97.99M-60.1% | -$61.2M+3.8% | -$63.64M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Whitehawk Therapeutics, Inc. Common Stock generate?
- Whitehawk Therapeutics, Inc. Common Stock (WHWK) generated -$107.8M in operating cash flow over the trailing twelve months.
- What is Whitehawk Therapeutics, Inc. Common Stock's free cash flow?
- After $738.0K of capital expenditures, Whitehawk Therapeutics, Inc. Common Stock's free cash flow was -$107.8M over the trailing twelve months, down 102.5% year over year.
- Where does Whitehawk Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Whitehawk Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.